We will know by November whether a safe, effective vaccine is coming


Key words



Proximity to the person wearing the costume: Anthony Fauci, director of the National Allergy and Infectious Diseases: 'The way registration is going and the level of infection in the United States, we are likely to get an answer by the end of the year.  '


Getty Images
Antini Fausi, director of the National Institute of Allergy and Infectious Diseases: ‘The way registration is going and the level of infection in the United States, the chances are we will get an answer. By the end of the year. ‘

How long until a safe, effective vaccine arrives?

The director of the National Institute of Allergy and Infectious Diseases and an infectious disease specialist for the last four decades, Dr. Anthony Fauci said this week: “The way registration is going and the level of infection in the United States is likely to get a response by the end of the year. “

“The pace of registration and the level of infection in the United States is likely to get a response by the end of the year,” he said. It is conceivable that we will get an answer before then. – Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases

He added: “It’s imaginable that we get an answer before then.” Meanwhile, U.S. Cases continue to rise in while California became the first state in the country to surpass 700,000 confirmed cases; There, the infection reached 705,951 with 12,937 COVID-related deaths as of Monday. 434,100 infections have been reported in New York and U.S. (32,951). COVID is a U.S. In 183,258 people have been killed

Loading ...

Load error

He told the Times newspaper in the UK that he declined to comment on what could be the next runner in the vaccine, but added: “I would say the safe bet is to know at least that by November, December you have a safe and Is an effective vaccine. ” “I will not be satisfied until the vaccine has proved safe and effective, before it is actually approved for general use.”

But for political purposes without knowing that it is safe to run the vaccine for political purposes. “We’re delivering life-saving treatments, and we’re going to produce the vaccine before the end of the year, or maybe sooner,” President Donald Trump told the Republican National Convention, mostly Republican. We will defeat the virus, end the epidemic and become stronger than before. ”

The President’s convention address appeared to accelerate somewhat of the timeline set by “Operation Operation and War Speed”, his administration’s efforts to economically support the rapid development, production and distribution of the COVD-19 vaccine, therapeutic and diagnostic. Under the program, the administration says its goal is to make the initial vaccine dose available by January 2021.

As of Monday, COVID-19 has infected more than 250 million people worldwide, mostly not responsible for asymptomatic cases, and killed 847,400 people. The U.S. still has the highest number of Covid-19 cases in the world (6,009,899), followed by Brazil (3,862,311), India (3,621,245) and Russia (992,402), according to data collected by Johns Hopkins University.

Ox AstraZeneca (AZN) in conjunction with Oxford University; Biotech SE (BNTX) and Partner Pfizer (PFE); GlaxoSmithKline (GSK) Johnson & Johnson (JNJ); Merck & Co. (ID: MERK); Modern (mRNA); Sanofi (SAN) is currently among those working on the Covid-19 vaccine.

See also: Sweden accepted mob immunity, while the UK dropped the idea – then why do they both have COVID-19 mortality?

In a separate interview with the “Colors” podcast on Friday, Fuui said it was imperative to enroll a variety of people in different vaccines to ensure it is safe and effective for everyone, and said the coronavirus flows “very bright light” in the U.S. On the inequality of the health-care system. Even after the vaccine, he said he needed to do something about the disparities.

‘African Americans are more likely to be infected than whites or others, and – when and if they are infected – are more likely to have serious consequences than whites. The answer is unfortunately, ‘yes,’ to both. ‘ – Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases

“There are two elements that need to be clarified,” Fawcett told podcast hosts JJ Green and Chris Core. “A: There is a possibility that whites or other people will be infected against African Americans and – when and if they do get infected – with even more serious consequences than whites.” The answer, unfortunately, is ‘yes’ to both. ”

He said, “You want to show that it is safe and effective in all elements of society. If we don’t find African Americans and Latinos and Asian Americans and Native Americans, if we don’t present them as accurately as they are at the hearing, we won’t know for sure – though, you may believe, but you want to prove it – That it is safe and effective in the group. ”

But experts warn that the vaccine is unlikely to give the population 100% immunity. Aside from social distance and masks, Fawcett had previously said that instead of closing schools and businesses to flatten the curve of the new case of Covid-1 – aimed at 100% mob immunity – there would be dire consequences for the American people.

Swedish pathologist Anders Tagnell, the mastermind of the plan, acknowledged that the country was making a mistake. “If we were to face the same disease of knowledge that we have today, I think our response would fall somewhere between what Sweden has done and what the rest of the world has done.” The highest mortality rate in Europe.

Countries such as South Korea, New Zealand and China – where the virus is thought to have contracted in Wuhan’s food market late last year – have been more successful in beating COVID-19. Earlier this week, for example, New Zealand moved quickly to lock uck calendars after COVID returned after reports of no infection after 102 days.

The Dow Jones Industrial Average (DJIA), the S&P 500 (SPX) and the Nasdaq Composite (COP) were lower on Monday. The speech by Federal Reserve Chairman Jerome Powell last week, analysts say, will help usher in an era of loose monetary policy after the central bank’s long-running practice of excessive rate hikes to curb inflation.

Continue reading